𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lung cancer in patients aged 50 years and younger: Clinical characteristics, treatment details and outcome

✍ Scribed by Veness, MJ ;Delaney, G ;Berry, M

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
91 KB
Volume
43
Category
Article
ISSN
0004-8461

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The impact of mammography in 1096 consec
The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993. Equal value for patients younger and older than age 50 years
✍ Hiram S. Cody III πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 472 KB πŸ‘ 1 views

Background. Although the benefit of screening mammography in healthy women younger than age 50 remains controversial, few studies have addressed the impact of mammography over time and by patient age, on means of diagnosis and stage of disease among women with breast cancer. Methods. One thousand n

Phase 2 trial of docetaxel and gefitinib
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older
✍ George R. Simon; Martine Extermann; Alberto Chiappori; Charles C. Williams; Mube πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 2 views

## Abstract ## BACKGROUND This is a phase 2 study of chemotherapy‐naive patients, 70 years of age or older, with nonsmall‐cell lung cancer (NSCLC) who were treated with docetaxel and gefitinib. The primary endpoint was response rate (RR). Secondary endpoints were overall survival (OS) and progress